RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R10310 | E7080; E7080; Lenvatinib Intermediate2 | Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5 |
| R10311 | E7080; E7080; Lenvatinib Intermediate3 | Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5 |
| R10312 | E7080; E7080; Lenvatinib Intermediate4 | Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5 |
| R10313 | KU0059436; AZD2281; OlaparibIntermediate | Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1/2 with IC50 of 5 |
| R10314 | PD0332991; PD0332991; Palbociclib | Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 wi |
| R10315 | PD0332991; Palbociclib Intermediate1 | Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 wi |
| R10316 | PD0332991; Palbociclib Intermediate2 | Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 wi |
| R10317 | PD0332991; Palbociclib Intermediate3 | Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 wi |
| R10318 | Valsartan/sacubitril; LCZ696 Intermediate1 | LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally |
| R10319 | Valsartan/sacubitril; LCZ696 Intermediate2 | LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally |
| R10320 | Valsartan/sacubitril; LCZ696 Intermediate3 | LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally |
| R10321 | MS37452 | |
| R10322 | Ryuvidine | Ryuvidine is a potent inhibitor of SET domain-containing protein 8(SETD8) with a |
| R10329 | Elafibranor;GFT505;GFT-505;GFT 505 | Elafibranor is an agonist of the peroxisome proliferator-activated receptor-α an |
| R10330 | GFT505; elafibranor E | Elafibranor is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. |
| R10331 | Cabozantinib S-malate (XL184 S-malate; BMS-907351 S-malate) | abozantinib malate (XL184) is the malate of Cabozantinib, a potent VEGFR2 inhibi |
| R10332 | Molibresib (Synonyms: GSK 525762A; I-BET 762) | Molibresib (GSK 525762A; I-BET 762) is a BET bromodomain inhibitor with IC50 of |
| R10333 | Navitoclax (Synonyms: ABT-263) | ABT-263 (Navitoclax) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki of |
| R10334 | SU6656 | SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 1 |
| R10336 | Felbamate; Felbatol | Felbamate (Felbatol) is an anticonvulsant drug used in the treatment of epilepsy |
| R10339 | PLX-3397; Pexidartinib | Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinas |
| R10341 | BS-181 hydrochloride | BS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more t |
| R10342 | GW 627368 | GW627368(GW627368X) is a novel, potent and selective competitive antagonist of p |
| R10343 | Bikinin; Abrasin | Bikinin is an ATP-competitive Arabidopsis GSK-3 inhibitor, and acts as a strong |
| R10344 | GW9662 | GW9662 is a selective PPAR antagonist for PPARγ with IC50 of 3.3 nM in a cell-fr |
